Skip to content

Efficacy of Poststroke Intensive Rosuvastatin Treatment for Aortogenic Embolic Stroke (EPISTEME trial)

Efficacy of Poststroke Intensive Rosuvastatin Treatment for Aortogenic Embolic Stroke (EPISTEME trial) - Efficacy of Rosuvastatin therapy for aortogenic embolic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010548
Enrollment
100
Registered
2013-04-19
Start date
2012-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain infarction or transient ischemic attack with atheromatous plaques in the aortic arch

Interventions

Treatment with rosuvastatin 5mg daily Treatment without rosuvastatin

Sponsors

Department of Neurology, Juntendo Universiy School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with brain infarction or transient ischemic attack within 7 days after onset, having atheromatous aortic plaques greater than 4mm in size 2) Patients with hypercholesterolemia (Serum LDL-C levels greater than 140mg/dL)

Exclusion criteria

Exclusion criteria: 1) Patients during pregnancy or lactation 2) Allergy against statin 3) Patients with coronary artery disease and requiring statin therapy 4) Patients with severe renal dysfunction or liver dysfunction 5) Patients undergoing cyclosporin therapy

Design outcomes

Primary

MeasureTime frame
Morphological alteration of atheromatous plaques in the aortic arch

Secondary

MeasureTime frame
1) Alteration of atheromatous plaques in the aortic arch 2) Changes in lipid profile 3) Changes in inflammatory markers and white blood cell count 4) Recurrence of ischemic stroke 5) Prevalence of hemorrhagic stroke including intracranial brain hemorrhage and subarachnoid hemorrhage 6) Prevalence of coronary artery disease 7) Other vascular diseases 8) Death

Countries

Japan

Contacts

Public ContactYuji Ueno

Juntendo University Urayasu Hospital Neurology

yuji-u@juntendo.ac.jo0473533111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026